Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 290

1.

Choroid plexus genes for CSF production and brain homeostasis are altered in Alzheimer's disease.

Kant S, Stopa EG, Johanson CE, Baird A, Silverberg GD.

Fluids Barriers CNS. 2018 Dec 12;15(1):34. doi: 10.1186/s12987-018-0120-7.

2.

Blood-Cerebrospinal Fluid Barrier Gradients in Mild Cognitive Impairment and Alzheimer's Disease: Relationship to Inflammatory Cytokines and Chemokines.

Ott BR, Jones RN, Daiello LA, de la Monte SM, Stopa EG, Johanson CE, Denby C, Grammas P.

Front Aging Neurosci. 2018 Aug 21;10:245. doi: 10.3389/fnagi.2018.00245. eCollection 2018.

3.

Comparative transcriptomics of choroid plexus in Alzheimer's disease, frontotemporal dementia and Huntington's disease: implications for CSF homeostasis.

Stopa EG, Tanis KQ, Miller MC, Nikonova EV, Podtelezhnikov AA, Finney EM, Stone DJ, Camargo LM, Parker L, Verma A, Baird A, Donahue JE, Torabi T, Eliceiri BP, Silverberg GD, Johanson CE.

Fluids Barriers CNS. 2018 May 31;15(1):18. doi: 10.1186/s12987-018-0102-9.

4.

Counteracting the effects of TNF receptor-1 has therapeutic potential in Alzheimer's disease.

Steeland S, Gorlé N, Vandendriessche C, Balusu S, Brkic M, Van Cauwenberghe C, Van Imschoot G, Van Wonterghem E, De Rycke R, Kremer A, Lippens S, Stopa E, Johanson CE, Libert C, Vandenbroucke RE.

EMBO Mol Med. 2018 Apr;10(4). pii: e8300. doi: 10.15252/emmm.201708300.

5.

Editorial: New Approaches to the Pathogenesis of Sudden Intrauterine Unexplained Death and Sudden Infant Death Syndrome.

Lavezzi AM, Johanson CE.

Front Neurol. 2017 Aug 28;8:441. doi: 10.3389/fneur.2017.00441. eCollection 2017. No abstract available.

6.

The Orphan C2orf40 Gene is a Neuroimmune Factor in Alzheimer's Disease.

Podvin S, Miller MC, Rossi R, Chukwueke J, Donahue JE, Johanson CE, Baird A, Stopa EG.

JSM Alzheimers Dis Relat Dement. 2016;3(1). pii: 1020. Epub 2016 Apr 1.

7.

A balanced view of the cerebrospinal fluid composition and functions: Focus on adult humans.

Spector R, Robert Snodgrass S, Johanson CE.

Exp Neurol. 2015 Nov;273:57-68. doi: 10.1016/j.expneurol.2015.07.027. Epub 2015 Aug 4. Review.

8.

Cell Junction Pathology of Neural Stem Cells Is Associated With Ventricular Zone Disruption, Hydrocephalus, and Abnormal Neurogenesis.

Guerra MM, Henzi R, Ortloff A, Lichtin N, Vío K, Jiménez AJ, Dominguez-Pinos MD, González C, Jara MC, Hinostroza F, Rodríguez S, Jara M, Ortega E, Guerra F, Sival DA, den Dunnen WF, Pérez-Fígares JM, McAllister JP, Johanson CE, Rodríguez EM.

J Neuropathol Exp Neurol. 2015 Jul;74(7):653-71. doi: 10.1097/NEN.0000000000000203.

PMID:
26079447
9.

A balanced view of choroid plexus structure and function: Focus on adult humans.

Spector R, Keep RF, Robert Snodgrass S, Smith QR, Johanson CE.

Exp Neurol. 2015 May;267:78-86. doi: 10.1016/j.expneurol.2015.02.032. Epub 2015 Mar 4. Review.

10.

Choroid plexus dysfunction impairs beta-amyloid clearance in a triple transgenic mouse model of Alzheimer's disease.

González-Marrero I, Giménez-Llort L, Johanson CE, Carmona-Calero EM, Castañeyra-Ruiz L, Brito-Armas JM, Castañeyra-Perdomo A, Castro-Fuentes R.

Front Cell Neurosci. 2015 Feb 6;9:17. doi: 10.3389/fncel.2015.00017. eCollection 2015.

11.

Amyloid-beta accumulation, neurogenesis, behavior, and the age of rats.

Church RM, Miller MC, Freestone D, Chiu C, Osgood DP, Machan JT, Messier AA, Johanson CE, Silverberg GD.

Behav Neurosci. 2014 Aug;128(4):523-36. doi: 10.1037/a0036433. Epub 2014 May 19.

PMID:
24841744
12.

The nexus of vitamin homeostasis and DNA synthesis and modification in mammalian brain.

Spector R, Johanson CE.

Mol Brain. 2014 Jan 10;7:3. doi: 10.1186/1756-6606-7-3. Review.

13.

Sustained choroid plexus function in human elderly and Alzheimer's disease patients.

Spector R, Johanson CE.

Fluids Barriers CNS. 2013 Sep 24;10(1):28. doi: 10.1186/2045-8118-10-28.

14.

Pediatric idiopathic intracranial hypertension and the underlying endocrine-metabolic dysfunction: a pilot study.

Salpietro V, Mankad K, Kinali M, Adams A, Valenzise M, Tortorella G, Gitto E, Polizzi A, Chirico V, Nicita F, David E, Romeo AC, Squeri CA, Savasta S, Marseglia GL, Arrigo T, Johanson CE, Ruggieri M.

J Pediatr Endocrinol Metab. 2014 Jan;27(1-2):107-15. doi: 10.1515/jpem-2013-0156.

PMID:
24025722
15.

Prevalence and correlates of street-obtained buprenorphine use among current and former injectors in Baltimore, Maryland.

Genberg BL, Gillespie M, Schuster CR, Johanson CE, Astemborski J, Kirk GD, Vlahov D, Mehta SH.

Addict Behav. 2013 Dec;38(12):2868-73. doi: 10.1016/j.addbeh.2013.08.008. Epub 2013 Aug 17.

16.

Vulnerability of fourth ventricle choroid plexus in sudden unexplained fetal and infant death syndromes related to smoking mothers.

Lavezzi AM, Matturri L, Del Corno G, Johanson CE.

Int J Dev Neurosci. 2013 Aug;31(5):319-27. doi: 10.1016/j.ijdevneu.2013.04.006. Epub 2013 May 13.

PMID:
23680292
17.

Steps physicians report taking to reduce diversion of buprenorphine.

Yang A, Arfken CL, Johanson CE.

Am J Addict. 2013 May-Jun;22(3):184-7. doi: 10.1111/j.1521-0391.2012.00335.x.

PMID:
23617857
18.

Personality and the acute subjective effects of d-amphetamine in humans.

Kirkpatrick MG, Johanson CE, de Wit H.

J Psychopharmacol. 2013 Mar;27(3):256-64. doi: 10.1177/0269881112472564. Epub 2013 Jan 23.

19.

Core outcome measures for opioid abuse liability laboratory assessment studies in humans: IMMPACT recommendations.

Comer SD, Zacny JP, Dworkin RH, Turk DC, Bigelow GE, Foltin RW, Jasinski DR, Sellers EM, Adams EH, Balster R, Burke LB, Cerny I, Colucci RD, Cone E, Cowan P, Farrar JT, Haddox JD, Haythornthwaite JA, Hertz S, Jay GW, Johanson CE, Junor R, Katz NP, Klein M, Kopecky EA, Leiderman DB, McDermott MP, O'Brien C, O'Connor AB, Palmer PP, Raja SN, Rappaport BA, Rauschkolb C, Rowbotham MC, Sampaio C, Setnik B, Sokolowska M, Stauffer JW, Walsh SL.

Pain. 2012 Dec;153(12):2315-24. doi: 10.1016/j.pain.2012.07.035. Epub 2012 Sep 19.

20.

Temporal course of cerebrospinal fluid dynamics and amyloid accumulation in the aging rat brain from three to thirty months.

Chiu C, Miller MC, Caralopoulos IN, Worden MS, Brinker T, Gordon ZN, Johanson CE, Silverberg GD.

Fluids Barriers CNS. 2012 Jan 23;9(1):3. doi: 10.1186/2045-8118-9-3.

21.

Changes in brain β-amyloid deposition and aquaporin 4 levels in response to altered agrin expression in mice.

Rauch SM, Huen K, Miller MC, Chaudry H, Lau M, Sanes JR, Johanson CE, Stopa EG, Burgess RW.

J Neuropathol Exp Neurol. 2011 Dec;70(12):1124-37. doi: 10.1097/NEN.0b013e31823b0b12.

22.

Comparison of intranasal methamphetamine and d-amphetamine self-administration by humans.

Kirkpatrick MG, Gunderson EW, Johanson CE, Levin FR, Foltin RW, Hart CL.

Addiction. 2012 Apr;107(4):783-91. doi: 10.1111/j.1360-0443.2011.03706.x.

23.

Esophageal cancer related gene-4 is a choroid plexus-derived injury response gene: evidence for a biphasic response in early and late brain injury.

Podvin S, Gonzalez AM, Miller MC, Dang X, Botfield H, Donahue JE, Kurabi A, Boissaud-Cooke M, Rossi R, Leadbeater WE, Johanson CE, Coimbra R, Stopa EG, Eliceiri BP, Baird A.

PLoS One. 2011;6(9):e24609. doi: 10.1371/journal.pone.0024609. Epub 2011 Sep 14.

24.

Diversion and abuse of buprenorphine: findings from national surveys of treatment patients and physicians.

Johanson CE, Arfken CL, di Menza S, Schuster CR.

Drug Alcohol Depend. 2012 Jan 1;120(1-3):190-5. doi: 10.1016/j.drugalcdep.2011.07.019. Epub 2011 Aug 21.

PMID:
21862241
25.

Amyloid-beta transporter expression at the blood-CSF barrier is age-dependent.

Pascale CL, Miller MC, Chiu C, Boylan M, Caralopoulos IN, Gonzalez L, Johanson CE, Silverberg GD.

Fluids Barriers CNS. 2011 Jul 8;8:21. doi: 10.1186/2045-8118-8-21.

26.

Cue-induced craving for marijuana in cannabis-dependent adults.

Lundahl LH, Johanson CE.

Exp Clin Psychopharmacol. 2011 Jun;19(3):224-30. doi: 10.1037/a0023030.

27.

Ecrg4 expression and its product augurin in the choroid plexus: impact on fetal brain development, cerebrospinal fluid homeostasis and neuroprogenitor cell response to CNS injury.

Gonzalez AM, Podvin S, Lin SY, Miller MC, Botfield H, Leadbeater WE, Roberton A, Dang X, Knowling SE, Cardenas-Galindo E, Donahue JE, Stopa EG, Johanson CE, Coimbra R, Eliceiri BP, Baird A.

Fluids Barriers CNS. 2011 Jan 18;8(1):6. doi: 10.1186/2045-8118-8-6.

28.

Targeting choroid plexus epithelia and ventricular ependyma for drug delivery to the central nervous system.

Gonzalez AM, Leadbeater WE, Burg M, Sims K, Terasaki T, Johanson CE, Stopa EG, Eliceiri BP, Baird A.

BMC Neurosci. 2011 Jan 7;12:4. doi: 10.1186/1471-2202-12-4.

29.

Targeting the choroid plexus-CSF-brain nexus using peptides identified by phage display.

Baird A, Eliceiri BP, Gonzalez AM, Johanson CE, Leadbeater W, Stopa EG.

Methods Mol Biol. 2011;686:483-98. doi: 10.1007/978-1-60761-938-3_25.

30.

The blood-cerebrospinal fluid barrier: structure and functional significance.

Johanson CE, Stopa EG, McMillan PN.

Methods Mol Biol. 2011;686:101-31. doi: 10.1007/978-1-60761-938-3_4. Review.

PMID:
21082368
31.

Amyloid efflux transporter expression at the blood-brain barrier declines in normal aging.

Silverberg GD, Messier AA, Miller MC, Machan JT, Majmudar SS, Stopa EG, Donahue JE, Johanson CE.

J Neuropathol Exp Neurol. 2010 Oct;69(10):1034-43. doi: 10.1097/NEN.0b013e3181f46e25.

PMID:
20838242
32.

Choroid plexus failure in the Kearns-Sayre syndrome.

Spector R, Johanson CE.

Cerebrospinal Fluid Res. 2010 Aug 23;7:14. doi: 10.1186/1743-8454-7-14.

33.

Co-localization and regulation of basic fibroblast growth factor and arginine vasopressin in neuroendocrine cells of the rat and human brain.

Gonzalez AM, Taylor WM, Johanson CE, King JC, Leadbeater WE, Stopa EG, Baird A.

Cerebrospinal Fluid Res. 2010 Aug 13;7:13. doi: 10.1186/1743-8454-7-13.

34.

Human behavioral pharmacology, past, present, and future: symposium presented at the 50th annual meeting of the Behavioral Pharmacology Society.

Comer SD, Bickel WK, Yi R, de Wit H, Higgins ST, Wenger GR, Johanson CE, Kreek MJ.

Behav Pharmacol. 2010 Jul;21(4):251-77. doi: 10.1097/FBP.0b013e32833bb9f8.

35.

Cerebrolysin reduces blood-cerebrospinal fluid barrier permeability change, brain pathology, and functional deficits following traumatic brain injury in the rat.

Sharma HS, Zimmermann-Meinzingen S, Johanson CE.

Ann N Y Acad Sci. 2010 Jun;1199:125-37. doi: 10.1111/j.1749-6632.2009.05329.x.

PMID:
20633118
36.

Expanding treatment capacity for opioid dependence with office-based treatment with buprenorphine: National surveys of physicians.

Arfken CL, Johanson CE, di Menza S, Schuster CR.

J Subst Abuse Treat. 2010 Sep;39(2):96-104. doi: 10.1016/j.jsat.2010.05.004. Epub 2010 Jul 3.

PMID:
20598829
37.

Vectorial ligand transport through mammalian choroid plexus.

Spector R, Johanson CE.

Pharm Res. 2010 Oct;27(10):2054-62. doi: 10.1007/s11095-010-0162-2. Epub 2010 May 15. Review.

PMID:
20473558
38.

Brain ventricular volume and cerebrospinal fluid biomarkers of Alzheimer's disease.

Ott BR, Cohen RA, Gongvatana A, Okonkwo OC, Johanson CE, Stopa EG, Donahue JE, Silverberg GD; Alzheimer's Disease Neuroimaging Initiative.

J Alzheimers Dis. 2010;20(2):647-57. doi: 10.3233/JAD-2010-1406.

39.

Amyloid and Tau accumulate in the brains of aged hydrocephalic rats.

Silverberg GD, Miller MC, Machan JT, Johanson CE, Caralopoulos IN, Pascale CL, Heile A, Klinge PM.

Brain Res. 2010 Mar 4;1317:286-96. doi: 10.1016/j.brainres.2009.12.065. Epub 2010 Jan 4.

PMID:
20045398
40.

Amyloid deposition and influx transporter expression at the blood-brain barrier increase in normal aging.

Silverberg GD, Miller MC, Messier AA, Majmudar S, Machan JT, Donahue JE, Stopa EG, Johanson CE.

J Neuropathol Exp Neurol. 2010 Jan;69(1):98-108. doi: 10.1097/NEN.0b013e3181c8ad2f.

PMID:
20010299
41.

Cerebrolysin attenuates blood-brain barrier and brain pathology following whole body hyperthermia in the rat.

Sharma HS, Zimmermann-Meinzingen S, Sharma A, Johanson CE.

Acta Neurochir Suppl. 2010;106:321-5. doi: 10.1007/978-3-211-98811-4_60.

PMID:
19812972
42.
43.

Risk management and post-marketing surveillance for the abuse of medications acting on the central nervous system: expert panel report.

Johanson CE, Balster RL, Henningfield JE, Schuster CR, Anthony JC, Barthwell AG, Coleman JJ, Dart RC, Gorodetzky CW, O'Keeffe C, Sellers EM, Vocci F, Walsh SL.

Drug Alcohol Depend. 2009 Dec 1;105 Suppl 1:S65-71. doi: 10.1016/j.drugalcdep.2009.08.006. Epub 2009 Sep 23.

44.

Treatment modalities for leptomeningeal metastases.

Shapiro WR, Johanson CE, Boogerd W.

Semin Oncol. 2009 Aug;36(4 Suppl 2):S46-54. doi: 10.1053/j.seminoncol.2009.05.006. Review.

PMID:
19660683
45.

Risk management and post-marketing surveillance of CNS drugs: an introduction.

Balster RL, Johanson CE, Walsh SL.

Drug Alcohol Depend. 2009 Dec 1;105 Suppl 1:S1-3. doi: 10.1016/j.drugalcdep.2009.08.001. Epub 2009 Sep 9. No abstract available.

PMID:
19744805
46.

Low levels of amyloid-beta and its transporters in neonatal rats with and without hydrocephalus.

Deren KE, Forsyth J, Abdullah O, Hsu EW, Klinge PM, Silverberg GD, Johanson CE, McAllister JP 2nd.

Cerebrospinal Fluid Res. 2009 May 26;6:4. doi: 10.1186/1743-8454-6-4.

47.

Hippocampal RAGE immunoreactivity in early and advanced Alzheimer's disease.

Miller MC, Tavares R, Johanson CE, Hovanesian V, Donahue JE, Gonzalez L, Silverberg GD, Stopa EG.

Brain Res. 2008 Sep 16;1230:273-80. doi: 10.1016/j.brainres.2008.06.124. Epub 2008 Jul 14.

48.

Multiplicity of cerebrospinal fluid functions: New challenges in health and disease.

Johanson CE, Duncan JA 3rd, Klinge PM, Brinker T, Stopa EG, Silverberg GD.

Cerebrospinal Fluid Res. 2008 May 14;5:10. doi: 10.1186/1743-8454-5-10.

49.

The role of human drug self-administration procedures in the development of medications.

Comer SD, Ashworth JB, Foltin RW, Johanson CE, Zacny JP, Walsh SL.

Drug Alcohol Depend. 2008 Jul 1;96(1-2):1-15. doi: 10.1016/j.drugalcdep.2008.03.001. Epub 2008 Apr 24. Review.

50.

Apolipoprotein E, amyloid-beta, and blood-brain barrier permeability in Alzheimer disease.

Donahue JE, Johanson CE.

J Neuropathol Exp Neurol. 2008 Apr;67(4):261-70. doi: 10.1097/NEN.0b013e31816a0dc8. Review. Erratum in: J Neuropathol Exp Neurol. 2008 Jun;67(6):634.

PMID:
18379441

Supplemental Content

Loading ...
Support Center